1. Oestrogen treatment has previously been shown to induce the formation of large amounts of-a serum protein, vitellogenin (xenoprotein), in Xenopus laevi8. Vitellogenin was purified from serum by dimethylformamide precipitation and was shown to be homogeneous by a variety of electrophoretic techniques. 2. The molecular weight of vitellogenin was estimated by gel filtration to be about 6 x 105. The chemical constituents ofvitellogenin were determined and lead to the characterization of this protein as a serum calcium-binding glycolipophosphoprotein. 3. The extractable lipid accounted for 12% of vitellogenin, Gas-liquid-chromatographic analysis of the saponified lipid moiety showed the presence of palmitic acid, palmitoleic acid, stearic acid, oleic acid and linoleic acid in the molecular proportions 6.8: 1.5: 1.0 : 3.6: 1.4. 4. The carbohydrate moiety consisted of 0.4g of hexose, 0.77g of hexosamine and 0.18g of sialic acid/lOOg of vitellogenin. 5. The calcium and phosphorus contents were 0.85 and 1.65g/100g of vitellogenin respectively. 6. Serum from oestrogen-treated animals injected with 4sCaC12 contained 9.7 times the radioactivity present in serum from untreated 4sCaC12-injected animals.
Of the radioactivity due to 45CaCl2 in the serum of oestrogen-treated animals 72% was non-diffusible on dialysis. Of this activity 65.4% was associated with the vitellogenin band on cellulose acetate electrophoresis.
It has been shown that in response to oestrogen treatment the South African clawed toad Xenopus laevi8 synthesizes large quantities of a serum protein (Follett & Redshaw, 1967; Rudack & Wallace, 1968; Wallace & Dumont, 1968; Follett, Nicholls & Redshaw, 1968; Munday, Ansari, Oldroyd & Akhtar, 1968) , which we referred to as xenoprotein (Munday et al. 1968) . However, to avoid confusion in the literature we will adopt the generic term 'vitellogenin', as proposed by Pan, Bell & Telfer (1969) and adopted by Wallace (1970) . Xenopu.s vitellogenin therefore refers to our xenoprotein, to the SLPP of Wallace & Jared (1968) and to the lipophosphoprotein of Follett et al. (1968) . In our previous report (Munday et al. 1968) we showed that this protein could be isolated from the serum of oestrogen-treated animals by precipitation with dimethylformamide. In this paper we describe the chemical composition of vitellogenin and extend our previous work (Munday et al. 1968) Akhtar, unpublished work) . The blood was obtained by cardiac puncture and centrifuged; the serum was pooled and cooled to 0°C. The serum was then,treated with chilled 3.5m-dimethylformamide (3.7 ml/lOml of serum) and the resulting suspension adjusted to pH 7-7.5 with 0.2 M-acetic acid. The resulting thick precipitate was collected by centrifugation at 15000rev./min at 0°C for 45min and washed once with 2.5ml of 3.5M-dimethylformamide in 0.15M-NaCl. The gelatinous precipitate was collected as described above, dissolved in 0.3M-NaCl and dialysed for 12 h at 50C against four changes of water. The non-diffusible material was then freeze-dried (Munday et al. 1968) . In some cases vitellogenin was stored at 5°C as the gelatinous precipitate obtained before dialysis. Vitellogenin prepared in the above fashion has a pronounced green colour and in addition to the typical protein absorption at 280nm has absorption maxima at 400 and 700nm. Most of the green pigment in vitellogenin is extractable with the lipid moiety by using chloroformmethanol (2: 1, v/v). Protein concentrations in NaCl solution were determined by the biuret method (Gornall, Bardawill & David, 1949) .
Determination of calcium and phosphorus. Ca2+ was determined by the method of Duthie & McDonald (1960 (Swenson & Kern, 1968; Winzler, 1955) . Time-course experiments showed that hydrolysis at 100°C for 20min secured the maximal release of sialic acid from vitellogenin. Recovery experiments showed that sialic acid was stable under the hydrolysis conditions used, the average recovery being 95%. After hydrolysis the protein suspension was centrifuged and the supernatant containing the sialic acids was extracted twice with ether to remove the trichloroacetic acid (Swenson & Kern, 1968 ). The aqueous phase was then assayed for sialic acids by the method of Svennerholm (1957) . Purified N-acetylneuraminic acid (Koch-Light Laboratories Ltd., Colnbrook, Bucks., U.K.) was used as standard.
Samples (50 mg) of native or lipid-extracted vitellogenin were hydrolysed in 2ml of 3M-HCI at 100°C for 7h. The hexosamine content of the hydrolysate was determined as glucosamine as described by Rondle & Morgan (1955) , with the modification of Kraan & Muir (1957) . The hydrolysis conditions employed did not cause significant destruction of the released hexosamines. Time-course experiments showed that 7 h hydrolysis released maximal quantities of hexosamines.
Samples (30 mg) of native or lipid-extracted vitellogenin were analysed for neutral sugars by the method outlined by Winzler (1955) with orcinol-sulphuric acid. An equimolar solution of galactose-mannose was used as a standard. Some turbidity was observed on the addition of the orcinol-sulphuric acid reagent to the native vitellogenin. This turbidity was partially removed by centrifugation in an MSE Minor bench centrifuge.
Extraction of lipid from vitellogenin. The delipidation of 0.5g of vitellogenin was carried out in a Soxhlet apparatus under N2 reflux with 200 ml of chloroform-methanol (2:1, v/v) for 12 h. The chloroform-methanol solution containing the extracted lipids was then partitioned by the addition of water (50 ml). The chloroform phase was dried over anhydrous sodium sulphate, evaporated to dryness and the ether-soluble residue was measured gravimetrically. The Soxhlet thimble containing the delipidated denatured protein was dried in a vacuum oven at 45°C for 6h and after air equilibration was re-weighed.
Saponification and methylation of vitellogenin lipid. Samples (60-120mg) of the lipid extracted from vitellogenin were saponified under N2 reflux with 10ml of methanolic 5% (w/v) KOH for 3h; water (10ml) was then added. The non-saponifable lipid was extracted from the hydrolysate twice with ether-light petroleum (b.p.
40-60°C) (1: 2, v/v). The aqueous phase was then acidified
with HCI and the saponified free fatty acids extracted with 2 x 50ml of the ether-light petroleum mixture. The extract was evaporated to dryness, redissolved in 3ml of ether and treated with diazomethane. The ether solution containing the methylated fatty acids was dried over anhydrous sodium sulphate and evaporated to dryness under N2. The residue was dissolved in a known volume of ethyl acetate and analysed by g.l.c.
Gas-liquid-chromatographic analysis. The samples were analysed on a Perkin-Elmer F 11 gas-liquiid chromatograph fitted with a disc integrator. A 2.5 m column containing polyethylene glycol-succinate ester on Chromosorb-P was used, with N2 as carrier gas. The conditions were: oven temperature 180°C; N2 pressure 16lb/in2; H2 pressure 15 lb/in2; air pressure 26 lb/in2 . Identification and quantitation of the peaks was performed by using standard fatty acid methyl esters obtained from the Hormel Instituite, University of Minnesota, Austin, Minn., U.S.A.
Determination of molecular weight. Bio-Gel A1.5m (100-200 mesh) was obtained from Calbiochem Ltd., London W.1, U.K. A glass column (25mmx760mm) was coated twice with dichlorodiethylsilane (1% solution in benzene) to minimize wall effects. The settled bed height was 710mm. The exclusion limit of the gel was 1.5 x 106 daltons. The column was equilibrated with 1.0 m-NaCl at a constant flow rate of 30 ml/h maintained by a constant-pressure-head device. The void volume was determined with Blue Dextran 2000 [Pharmacia (G.B.) Ltd., London W.13, U.K.] and the final volume with L-tyrosine (BDH Chemicals Ltd.). Protein samples (10-20mg of each protein) were placed on the column in 1.5ml of 1.OM-NaCl containing 10% (w/v) sucrose. The absorption of the column effluent was read and recorded automatically at 260nm with an LKB Unicord type 4701A monitor. A column of identical dimensions containing Sepharose 4B (Pharmacia Ltd.) was prepared in a similar fashion to the above. The exclusion limit of the Sepharose was 20 x 106 daltons.
Bovine thyroglobulin type 1, pepsin (twice recrystallized), catalase (bovine), bovine serum albuimin type F and haemoglobin (bovine) type 1 (twice recrystallized) obtained from Sigma (London) Chemical Co. Ltd., London S.W.6, U.K., were used as standards. The elution volume for pepsin was determined in the absernce of all other proteins.
Cellulose acetate electrophoresis. This was performed as described by Smith (1968a) , with 0.037M-sodium barbitone buffer, pH 8.6. After electrophoresis the cellulose acetate strips were stained with Ponceau S. Stained protein bands were cut into strips,dissolved in 1 ml of methylene chlorideethanol (9:1, v/v) and their radioactivities counted in 10ml of scintillator containing 0.8g of 5-(4-biphenylyl)-2-(4-tert.-butylphenyl)-1 -oxa-3,4-diazole (Koch-Light Ltd.) in 100ml of sulphur-free toluene. Radioactivity was determined in a Beckman CPM 200 liquid-scintillation spectrometer and the results were corrected to constant counting efficiency.
Polyacrylamide RESULTS Preparation of vitellogenin and ases88ment of ite purity. Vitellogenin was prepared from the serum ofoestrogen-treated animals essentially as described by Munday et al. (1968) and evaluated for its homogeneity by a variety of electrophoretic techniques. Fig. 1(a) shows a scan of serum from oestrogen-treated animals, 3 days after injection, run on 4% polyacrylamide gel. The magnitude of the response to oestrogen is readily seen by comparison with the pattern obtained from the serum of untreated animals (Fig. lb) . In a typical preparative procedure serum from animals injected with oestradiol 2-3 weeks previously was cooled to 00C, treated with dimethylformamide and the pH adjusted to 7-7.5, when a thick gelatinous precipitate was formed. About 100mg of vitellogenin can be obtained in this way from 1 ml of serum. The protein prepared by the above method runs as a single band when analysed by electrophoresis on starch gels (Plate 1), cellulose acetate strips or polyacrylamide gels (containing 4, 6 or 7.5% acrylamide). Fig. 2(a) shows a scan of vitellogenin precipitated from oestrogen-treated animals, 18 days after injection, and run on 4% acrylamide gels (also see Plate 2). The small albumin impurity (2-4%) present in the dimethylformamide precipitate can be readily removed by gel filtration. The purest samples ofvitellogenin are obtained when the precipitation is performed with large volumes of serum (20ml). The concentration of dimethylformamide and the adjustment of the pH to 7-7.5 appear to be critical factors in the purification and are sometimes inadequately achieved with smaller volumes of serum (1-2ml).
Results in can be stored at 40C in the form of a gelatinous precipitate for 4 weeks without any change in the electrophoresis pattern. However, several treatments, including exposure to low pH, storage in solution or gel filtration, resulted in the formation of two types of rearranged proteins with characteristic electrophoretic behaviour. Fig. 2(c) shows that storage for 14 days at 40C of a 30mg/ml saline solution of vitellogenin (originally containing band II only) resulted in the appearance of a protein of lower electrophoretic mobility (band I) than the main vitellogenin peak (band II). Band I is also present in low concentrations (up to 10% of band II) in unfractionated serum of animals that had been injected with oestradiol 3 weeks previously and were producing vitellogenin at maximal rates (A. Q. Ansari, P. J. Dolphin, C. B. Lazier, K. A. Munday & M. Akhtar, unpublished work). Preliminary evidence from ultracentrifugal analysis suggests that band I may represent an oligomeric form of vitellogenin. Fig. 2(b) shows another peak (band III), which is absent from the original dimethylformamide precipitate but which can be derived from it by exposure to low pH. Addition of 0.08ml of 0.2M-acetic acid to a 1 ml sample of vitellogenin (15 mg/ ml) that was originally homogeneous resulted in a precipitate, which on electrophoresis showed a 32% conversion into band III material. Vitellogenin, when subjected to gel filtration on Sepharose 4B, Bio-Gel Al.5m or Sephadex G-200, was eluted as a single peak. However, polyacrylamide-gel electrophoresis showed that bands II and III were present in all fractions of the effluent peak corresponding to vitellogenin (Fig. 3 , also see Fig. 2d ). The partial conversion of band II into band III after gel filtration coincides with the loss of bound calcium (Table 2) .
That these apparently simple manipulations cause the decomposition or rearrangement of vitellogenin illustrates the mildness and specificity of the dimethylformamide precipitation technique used to isolate the protein from serum.
Analysis of vitellogenin. Preparations of vitellogenin containing over 95% of band II and 2-4% of albumin were used for the analysis of carbohydrate, lipid, calcium and phosphorus reported in Table 2 . The analysis for carbohydrate was repeated with vitellogenin from which all the albumin had been removed by gel filtration (Fig. 2d) . As mentioned above, this procedure causes the conversion of some of band II into band III. It does not, however, significantly affect the carbohydrate content, but does result in the loss of bound calcium ( Table 2) . The analysis by g.l.c. of the saponifiable fatty acids in the lipid fraction of vitellogenin is shown in EXPLANATION OF PLATE Starch-gel electrophoresis. This was performed as described by Smith (1968b) with 0.027M-borate buffer, pH8.7, at a constant current of lOmA per tray applied for 6h. The gels were then fixed in 5% (v/v) acetic acid and stained in Amido Black. Polyacrylamide-gel electrophoresis of vitellogenin precipitated from the serum of oestrogen-treated animals. 18 days after injection, by the dimethylformamide method.
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The Biochemical Journal, Vol. 122, No. 1 was 75%. The values quoted in Table 3 are corrected for a 25% loss of fatty acid during the procedure.
Determination of molecular weight. The approximate molecular weight of vitellogenin was determined by comparing its mobility with that of known standards on columns of Bio-Gel A1.5m and tt tt Sepharose 4B. From a plot of log molecular weight versus elution volume the molecular weight of vitellogenin was estimated to be 5.9 x I05 on the former column and 6.7 x i05 on the latter. The estimate given by Wallace & Jared (1968) for the approximate molecular weight of vitellogenin determinedonagarose columns was 7 x 105, although more recent ultracentrifugal analysis gave a value of 4.6 x 105 (Wallace, 1970) .
Calcium-binding nature of vitellogenin. Previous work on the calcium-binding property of vitellogenin (Munday et al. 1968 ) was extended. First 20,uCi of 45CaCl2 solution was injected into the dorsal lymph sac of control and oestrogen-treated animals (18 days after hormone treatment) and serum samples were collected after 24h. Serum from oestrogen-treated animals contained 9.7 times (15.8 x 103 c.p.m./10,u) the amount of 45Ca radioactivity found in the serum of control animals (1.6 x 103 c.p.m./1Op.l). Vitellogenin, when precipitated from the serum of oestrogen-treated animals with dimethylformamide, contained 60% of the total 45Ca radioactivity present (9.5 x 103c.p.m. from IO ,ul of serum). Samples of serum from oestrogen-treated and control animals were dialysed against 0.15 M-sodium chloride for 6h at 5C to remove unbound 45Ca. Samples (10,l) of the dialysed serum from control and oestrogen-treated animals had 88c.p.m. and 11.4 x 103 c.p.m. respectively, thus showing that most of the 45Ca radioactivity in the serum of control animals was present in an unbound form. The electrophoretic pattern of the dialysed serum from oestrogen-treated animals showed that 65.4% (7.4 x 103 c.p.m.) of the total radioactivity present after dialysis was recovered bound to the vitellogenin band (Table 4) . This represents 47 % of the original 45Ca radioactivity of whole (undialysed) serum. In similar experiments (Munday et al. 1968) , only 23% of the 45Ca radioactivity was associated with the vitellogenin band on electrophoresis. The improvement in the present work was achieved primarily by avoiding delay in processing the serum after its removal from the animals. The cumulative evidence above suggests that about half of the 45Ca present in the serum of oestrogen-treated animals is bound to vitellogenin in a form which is stable to dialysis and electrophoresis.
DISCUSSION
The work described in this paper shows that the toad Xenopus laevis synthesized large amounts of a high-molecular-weight serum calcium-binding glycolipophosphoprotein in response to a single 1 mg dose of oestradiol (Munday et al. 1968 ). Wallace & Dumont (1968) and Follett & Redshaw (1968) The dimethylformamide method used in the present study made available vitellogenin which contained its associated calcium attached to the protein in a form stable to dialysis and electrophoresis. This observation is to be contrasted with the report that triethylaminoethylcellulose-purified vitellogenin contains no calcium (apparently lost during dialysis before chromatography) (Wallace, 1970) . Our work revealed that the process of gel filtration could cause the removal of calcium from vitellogenin. This result is compatible with that of Wallace (1970) , who found that serum from
[45Ca]calcium chloride-injected oestrogen-treated male toads gave no 45Ca radioactivity in the vitellogenin peak after gel filtration on agarose.
The atomic ratio of calcium to protein-bound phosphorus in the whole serum of oestrogentreated toads has been estimated to be 1.01 for males (Wallace, 1970) and 0.83 for females (Table 2 of Follett & Redshaw, 1968) . The ratio for the dimethylformamide-purified vitellogenin is 0.46. Whether the 50% decrease in the ratio is due to loss of calcium during purification or to some other factor cannot be assessed. This consideration, however, should not detract from the fact that the present work constitutes an example of the isolation of a protein that has retained much of the originally bound calcium during purification.
The formation and biosynthesis of new serum proteins in response to oestrogen treatment have in the past been extensively studied in avian species (Heald & McLachlan, 1965 Clegg (1968) . It is generally considered that these oestrogeninduced serum proteins in avian and amphibian species are precursors of the egg-yolk proteins. Credibility for this view is provided by the fact that a protein which is similar to or identical with serum phosvitin has been isolated from hen's egg-yolk (Joubert & Cook, 1958) . Further, Wallace & Jared (1969) (Wallace, 1963 (Wallace, , 1970 
